EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inflammatory Dynamics in Carbapenem-Resistant Klebsiella pneumoniae Hospital-Acquired and Ventilator-Associated Pneumonia Treated with Ceftazidime–Avibactam: Microbiological Response and 14-Day Mortality

Inflammatorische Dynamik bei carbapenemresistenter Klebsiella pneumoniae bei nosokomialer und ventilatorassoziierter Pneumonie unter Ceftazidim–Avibactam: mikrobiologische Antwort und 14-Tage-Mortalität

Mine Filiz, Elmas Emsal Aydoğdu, Ertuğrul Yazıcı, Aysun Yalçı, Mete Erdemir, Bayhan Bektöre

Antibiotics · 07.11.2026 · 15 (11) · 1101

DOI: 10.3390/antibiotics15111101 ↗

Auf einen Blick

Bei 125 Erwachsenen mit CRKP-HAP/VAP war ein schnellerer CRP-Abfall mit früher mikrobiologischer Clearance verbunden. Ein höherer IBI an Tag 3 war mit 14-Tage-Mortalität assoziiert.

Fragestellung

Ob frühe inflammatorische Dynamik und hämatologische Indizes zusätzliche Hinweise auf mikrobiologische Antwort und 14-Tage-Mortalität bei CRKP-HAP/VAP unter Ceftazidim–Avibactam liefern.

Methode

Einzentrische retrospektive Beobachtungsstudie mit 125 Erwachsenen; CRPv, IBI, SII, SIRI und PIV zu Behandlungsbeginn und nach etwa 72 h; ROC-Analysen und multivariable logistische Regression.

Ergebnisse

Mikrobiologische Clearance bei 89 Patienten (71,2 %), 39 starben innerhalb von 14 Tagen. CRPv: OR 0,434 (95 %-KI 0,256–0,737) für Clearance; AUC 0,743. Tag-3-IBI: OR 1,029 pro 100 Einheiten (95 %-KI 1,005–1,053) für Mortalität.

Einschränkungen

Explorative Befunde; keine signifikante Verbesserung der AUC durch die Biomarker über klinische Basismodelle hinaus.

Schlussfolgerung der Autor:innen

Frühe inflammatorische Dynamik kann die Basis-Schweregradbeurteilung bei CRKP-HAP/VAP ergänzen. Ein schnellerer CRP-Abfall war mit früher mikrobiologischer Antwort verbunden, höheres Tag-3-IBI mit 14-Tage-Mortalität.

Kernaussagen

  • CRPv war unabhängig mit mikrobiologischer Clearance assoziiert.
  • Höheres Tag-3-IBI war mit 14-Tage-Mortalität assoziiert.
  • SII, SIRI und PIV zeigten keine konsistenten unabhängigen Zusammenhänge.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 07.11.2026. Verfasst von Mine Filiz und 5 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

Auf einen BlickAbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Carbapenem-resistant Klebsiella pneumoniae (CRKP) hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) remain associated with substantial treatment failure and mortality despite ceftazidime-avibactam therapy. We investigated whether early inflammatory dynamics and hemogram-derived indices could provide additional information regarding microbiological response and short-term mortality.

Methods

This single-center retrospective observational study included 125 adults with CRKP HAP/VAP treated with ceftazidime–avibactam between January 2021 and January 2026. C-reactive protein velocity (CRPv), inflammatory burden index (IBI), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and pan-immune-inflammation value (PIV) were assessed at treatment initiation and approximately 72 h later. The primary outcome was microbiological clearance at 48–72 h, and the secondary outcome was 14-day all-cause mortality. Receiver operating characteristic (ROC) analyses and multivariable logistic regression models adjusted for Pitt bacteremia score and bacteremia status were performed.

Results

Microbiological clearance occurred in 89 patients (71.2%), while 39 (31.2%) died within 14 days. CRPv was independently associated with microbiological clearance (odds ratio (OR) 0.434, 95% confidence interval (CI) 0.256–0.737; p = 0.002), and the CRPv-adjusted model showed an area under the curve (AUC) of 0.743. Among patients who survived and remained evaluable at day 3, higher day-3 IBI was independently associated with mortality within 14 days of ceftazidime–avibactam initiation (OR, 1.029 per 100-unit increase; 95% CI, 1.005–1.053; p = 0.018). SII, SIRI, and PIV showed no consistent independent associations. None of the evaluated biomarkers significantly increased the AUC beyond the clinical baseline models.

Conclusions

Early inflammatory dynamics may complement baseline severity assessment in CRKP HAP/VAP. A faster CRP decline was independently associated with early microbiological response. Higher day-3 IBI was associated with 14-day mortality among patients who survived and remained evaluable at approximately day 3. These readily available markers may support early reassessment of treatment and risk stratification, although these exploratory findings require validation before clinical application.

Zitieren

APA

Filiz, M., Aydoğdu, E. E., Yazıcı, E., Yalçı, A., Erdemir, M., & Bektöre, B. (2026). Inflammatory Dynamics in Carbapenem-Resistant Klebsiella pneumoniae Hospital-Acquired and Ventilator-Associated Pneumonia Treated with Ceftazidime–Avibactam: Microbiological Response and 14-Day Mortality. Antibiotics, 15(11), 1101. https://doi.org/10.3390/antibiotics15111101

Vancouver

Filiz M, Aydoğdu EE, Yazıcı E, Yalçı A, Erdemir M, Bektöre B. Inflammatory Dynamics in Carbapenem-Resistant Klebsiella pneumoniae Hospital-Acquired and Ventilator-Associated Pneumonia Treated with Ceftazidime–Avibactam: Microbiological Response and 14-Day Mortality. Antibiotics. 2026;15(11):1101. doi:10.3390/antibiotics15111101

BibTeX
@article{Filiz2026,
  author = {Filiz, Mine and Aydoğdu, Elmas Emsal and Yazıcı, Ertuğrul and Yalçı, Aysun and Erdemir, Mete and Bektöre, Bayhan},
  title = {Inflammatory Dynamics in Carbapenem-Resistant Klebsiella pneumoniae Hospital-Acquired and Ventilator-Associated Pneumonia Treated with Ceftazidime–Avibactam: Microbiological Response and 14-Day Mortality},
  journal = {Antibiotics},
  year = {2026},
  volume = {15},
  number = {11},
  pages = {1101},
  doi = {10.3390/antibiotics15111101}
}
Kostenlos starten →